Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, has launched ProPhet, a startup using artificial intelligence to locate small molecules for drug discovery.
ProPhet was established following AION Labs' startup challenge focused on AI-powered drug discovery of new high-affinity small molecules.
The aim is to address the market need to speed...
